Zobrazeno 1 - 10
of 172
pro vyhledávání: '"Yoshiyasu, Karino"'
Autor:
Fumitaka Suzuki, Yoshiyuki Suzuki, Yoshiyasu Karino, Yasuhito Tanaka, Masayuki Kurosaki, Hiroshi Yatsuhashi, Tomofumi Atarashi, Masanori Atsukawa, Tsunamasa Watanabe, Masaru Enomoto, Masatoshi Kudo, Naoto Maeda, Hiroshi Kohno, Kouji Joko, Kojiro Michitaka, Koichiro Miki, Kazuhiro Takahashi, Tatsuya Ide, Shigetoshi Fujiyama, Tomoko Kohno, Hiroshi Itoh, Sakiyo Tsukamoto, Yuko Suzuki, Yoshiaki Kawano, Wataru Sugiura, Hiromitsu Kumada
Publikováno v:
BMC Gastroenterology, Vol 21, Iss 1, Pp 1-10 (2021)
Abstract Background Tenofovir disoproxil fumarate (TDF) is widely used and recommended as first-line treatment for patients infected with the hepatitis B virus (HBV). However, current data are limited regarding the efficacy and safety of switching to
Externí odkaz:
https://doaj.org/article/5e091e3f103d4f72a3d10616da4a9749
Autor:
Tomoaki Nakajima, Yoshiyasu Karino, Shuhei Hige, Hirokazu Suii, Ryoji Tatsumi, Masakatsu Yamaguchi, Tomohiro Arakawa, Yasuaki Kuwata, Joji Toyota
Publikováno v:
Annals of Hepatology, Vol 27, Iss 1, Pp 100566- (2022)
Introduction and objectives: Sustained virologic response (SVR) is achieved in most cases of C-type liver disease after direct-acting antiviral (DAA) therapy. Although liver fibrosis improves, the degree of improvement is different. This study aimed
Externí odkaz:
https://doaj.org/article/d659d04c2d2e4abe8c4707760d54fff6
Autor:
Hirokazu Suii, Itaru Ozeki, Ryoji Tatsumi, Masakatsu Yamaguchi, Mutsuumi Kimura, Tomohiro Arakawa, Tomoaki Nakajima, Yasuaki Kuwata, Takumi Ohmura, Shuhei Hige, Yoshiyasu Karino, Joji Toyota
Publikováno v:
Case Reports in Hepatology, Vol 2017 (2017)
Interferon (IFN) and ribavirin (RBV) combination therapy was previously the standard of care for treatment of hepatitis C virus (HCV) genotype 2 infection. But, it often induced hemolytic anemia. In 2014, sofosbuvir (SOF) was approved for the treatme
Externí odkaz:
https://doaj.org/article/23cfa00cf20f4f2f9b8d02ccaeb67c97
Publikováno v:
Diagnostics, Vol 4, Iss 3, Pp 94-103 (2014)
Gastric varices that arise secondary to the splenic vein occlusion can result in gastrointestinal hemorrhaging. Endoscopic color Doppler ultrasonography (ECDUS) was performed in 16 patients with gastric varices secondary to splenic vein occlusion. Th
Externí odkaz:
https://doaj.org/article/6ac0ad48414a453ba877e4b43130fa8c
Autor:
Yoshiyasu Karino, Takumi Kawaguchi, Motoh Iwasa, Hiroyuki Nakanishi, Yasuhiko Sawada, Hisamitsu Miyaaki, Kiwamu Okita, Tomoaki Nakajima, Hitoshi Yoshiji, Atsushi Hiraoka, Makoto Shiraki, Kazuhiko Koike
Publikováno v:
Journal of Gastroenterology. 55:868-876
Administration of diuretics and the presence of ascites in patients with cirrhosis were reported to be associated with muscle cramps; however, the clinical evidence is limited. This study aimed to determine whether muscle cramps are a diuretic-induce
Autor:
Yoshiyasu Karino, Johannes Vermehren, Xiaoming Cheng, Marcus M. Mücke, Shuhei Hige, Hiroshi Aikata, Takuro Uchida, Anuj Gaggar, Stefan Zeuzem, Pei-Jer Chen, T. Jake Liang, Chun-Jen Liu, Nami Mori, Yuchen Xia, Mitsutaka Osawa, Yuji Teraoka, Kazuaki Chayama, Michio Imamura, Keiji Tsuji, Vithika Suri, Regina Umarova
Publikováno v:
J Clin Invest
In patients with HBV and HCV coinfection, HBV reactivation leading to severe hepatitis has been reported with the use of direct-acting antivirals (DAAs) to treat HCV infection. Here we studied the molecular mechanisms behind this viral interaction. I
Autor:
Tomoaki Nakajima, Tomohiro Arakawa, Ryoji Tatsumi, Yoshiyasu Karino, Itaru Ozeki, Yasuaki Kuwata, Masakatsu Yamaguchi, Hirokazu Suii, Joji Toyota
Publikováno v:
Hepatology Research. 50:488-501
Aim In Japan, no zinc preparation had been approved for therapeutic purposes before March 2017. Zinc acetate hydrate was recently approved for the treatment of hypozincemia. We evaluated the efficacy and safety of treatment with zinc acetate hydrate.
Autor:
Tomohiro Arakawa, Hirokazu Suii, Joji Toyota, Shuhei Hige, Yasuaki Kuwata, Yoshiyasu Karino, Masakatsu Yamaguchi, Tomoaki Nakajima, Ryoji Tatsumi
Publikováno v:
Annals of Hepatology, Vol 27, Iss 1, Pp 100566-(2022)
Introduction and objectives: Sustained virologic response (SVR) is achieved in most cases of C-type liver disease after direct-acting antiviral (DAA) therapy. Although liver fibrosis improves, the degree of improvement is different. This study aimed
Autor:
Man-Fung Yuen, Jeong Heo, Hiromitsu Kumada, Fumitaka Suzuki, Yoshiyuki Suzuki, Qing Xie, Jidong Jia, Yoshiyasu Karino, Jinlin Hou, Kazuaki Chayama, Michio Imamura, Judy Y. Lao-Tan, Seng Gee Lim, Yasuhito Tanaka, Wen Xie, Jung-Hwan Yoon, Zhongping Duan, Masayuki Kurosaki, Sung-Jae Park, Madalinee Eternity Labio, Rajneesh Kumar, Young-Oh Kweon, Hyung Joon Yim, Yu Tao, Jennifer Cremer, Robert Elston, Matt Davies, Sharon Baptiste-Brown, Kelong Han, Fiona M. Campbell, Melanie Paff, Dickens Theodore
Publikováno v:
Journal of hepatology. 77(4)
Bepirovirsen, an antisense oligonucleotide targeting pregenomic and mRNA transcripts of HBV, has been conjugated to N-acetyl galactosamine (GSK3389404) to enhance hepatocyte delivery. This dose-finding study was the first to assess GSK3389404 for chr
Autor:
M Paff, M Davies, Seng Gee Lim, J Heo, Yukiko Suzuki, Yasuhito Tanaka, H Kumada, J Cremer, Zhongping Duan, YO Kweon, JY lao-Tan, SJ Park, M Kurosaki, K Chayama, JH Yoon, E Labio, Jinlin Hou, D Theodore, Yoshiyasu Karino, S Baptiste-Brown, W Xie, M Imamura, Q Xie, F Suzuki, R Kumar, Rmf Yuen, Sixia Chen, F Campbell, R Elston, HJ Yim, Jidong Jia, Kwang Hyub Han
Publikováno v:
Hepatology. 70:188-1382